Clinical Trial Update: Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial update for Yttrium-90 radiation segmentectomy in unresectable hepatocellular carcinoma. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 radiation segmentectomy (Yttrium-90 radiotherapy)

Snippet

Sponsor: University of California, San Francisco | Conditions: Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma | NA | Status: NOT_YET_RECRUITING